Wednesday, August 27, 2014

The Health Minister Drisun visited Zelltek SA



     Dr. Mario Drisun (Health Minister of Santa Fe and Chairman of LIF’s Executive Committee) together with Dr. Javier Lottersberg (Dean of Biochemistry and Biological Sciences School - UNL), visited Zelltek SA.
     Rogelio Pujol (Sales Manager) and Rubén Zurbriggen (Institutional Relations) by Zelltek welcomed the visitors.
     Miguel González (Health Secretary), Elvia Gómez (Director of Biochemistry and Pharmacy - Health Ministry), Guillermo Cleti (LIF’s Director) and Carlos Arques (LIF’s Director) also participated in the meeting.
     Zelltek SA produces active biopharmaceutical ingredients in a production site located at the Parque Tecnológico Litoral Centro (Santa Fe).
     In August 2013, LIF and Zelltek signed an agreement of “Mutual collaboration and assistance”.
     Due to this agreement, LIF will be able to provide biogenerics such as Erythropoietin, Interferon and Filgrastim. And, in this way, add a new products line in its portfolio, which so far only includes medicines for primary healthcare.

Meeting of Public Laboratories at the National Health Ministry

phpv69r7z.jpg (400×254)
     The activity took place at the “Minister Oñativia Room” where different public laboratories of medicines from all the country, attended.
     Carlos Arques, Diego Bruno and Guillermo Cleti, (LIF’s Directors) have participated in a meeting at the National Health Ministry (NHM).
     The activity took place at the “Minister Oñativia Room” where different public laboratories of medicines from all the country, attended.
     Dr. Daniel Gollan (Community Health Secretary - NHM) led the meeting.
     Dr. Jorge Zarzur (Executive Director of the National Program of State Production of Medicines, Vaccines and Medical Devices) also participated.
     The attendees analyzed the current production capacity of all the public laboratories and evaluated different financing tools to improve the production volumes of each laboratory.
     Finally, they talked about the specialization of each of the laboratories which is expected to be more efficient in the future.



     Members of Laboratorios Puntanos (San Luis); Laboratorio de Hemoderivados (UNC - Córdoba); Laboratorio de Especialidades Medicinales (LEM de Rosario); Productora Zonal de Medicamentos (Prozome - Río Negro); Laformed (Formosa); LEMIS (Misiones); Instituto Biológico Tomás Perón (La Plata); Lapromed (Mendoza) and Laboratorio del Chaco were presents in this meeting.

Wednesday, August 13, 2014

Meeting at India's Embassy

     
     Guillermo Cleti, LIF’s Director, had a meeting at India’s Embassy in Argentina.
     Amarendra Khatua (India’s Ambassador); Sudhanshu Pandey (Joint Secretary, Department of Commerce - Ministry of Commerce & Industry), P.V. Appaji (Pharmexcil’s General Director)* and Juan Müller (LEM’s Director)** participated in the meeting which took place at India’s Embassy in Buenos Aires.


     Guillermo Cleti gave information about the different API’s that LIF uses to produce medicines. A lot of them are produced by Indian laboratories.
     “We would like to import some API’s directly from India. Today LIF buys these raw materials in the local market. We want to improve our production costs”, said Guillermo Cleti.
     Also, Guillermo Cleti talked about the project for research, development and production of medicines for patients with tuberculosis diseases.
     “Indian laboratories make a lot of these raw materials. In the future, LIF is going to use a lot of them. This contact with Indian laboratories will be very useful when we need to develop our formulas”, said Cleti.
     P.V. Appagy and Sudhanshu Pandey asked Cleti about the LIF’s production of Orphan drugs. He gave information about: the production of ephedrine tablets for only one child with Myasthenia gravis and Hypertonic Saline to use in patients with Cystic Fibrosis.
     Production of biogenerics was another topic in the agenda.

Link with India.
     On February, 2014, Guillermo Cleti travelled to India as one of the members of the Santa Fe Government’s Mission.He had a schedule of meetings with different Indian companies, mainly medicines manufactures and APIs manufacturers.


*Pharmexcil: Pharmaceuticals Export Promotion Council of India.
API’s: Active Pharmaceutical Ingredient.
**LEM SE: Laboratorio de Especialidades Medicinales, Sociedad del Estado. It is the Rosario’s city hall public laboratory.

Friday, August 8, 2014

Lecture at Lawyers’ College in Rosario

     
phpvdjewp.jpg (400×300)
     Guillermo Cleti, LIF’s Director, participated in a lecture about medicines in Rosario.
     The meeting took place at the Lawyers’ College headquarters on August 1st.
     The main topics were: Patient rights to access to medicines; Patient safety against illegitimate medicines; drugs coverage and Public production of medicines.
     Firstly, Guillermo Cleti gave information about the public production of medicines in Argentina and Santa Fe province. Then, he talked about LIF’s history, legal framework and production of orphan drugs.
     Dra. Viviana Denk, Dr. Raúl Andrés Lassizuk, Dr. Carina Mazzeo and Dr. Julia Canet were other participants in the meeting.
     The activity was organized by Instituto de Derecho de la Salud y Bioética.

Wednesday, July 16, 2014

Research and Development of anti tuberculosis medicines


http://www.lifsantafe.com.ar/news/images/phpewoczm.jpg
     Dr. Mario Drisun (Health Minister of Santa Fe Province and LIF’s Chairman) participated in a press conference where LIF and UNL presented the project “Research and Development of anti tuberculosis medicines”.

     Dr. Albor Cantar (UNL’s Rector) and Eng. Carlos Arques (LIF’s Directors) also participated in the conference together with Dr. Drisun.
     The meeting took place at LIF’s headquarters where different UNL’s authorities, project’s members; LIF’s Directors and Managers, journalists and other health’s authorities were present.
     Through this project LIF and UNL* are going to research and develop four medicines for the treatment of tuberculosis:
-Rifampicin + Isoniazid + Pyrazinamide (triple association).
- Ethambutol.
- Rifampin + Isoniazid (double association).
- Isoniazid.

     “The meeting between LIF and UNL is an excellent strategy and an authentic example of state policy”, says Mario Drisun.
     “We want to produce these medicines in three years. In this way, we are going to achieve a solution for the National Government and mainly for all the patients in Argentina”, says Carlos Arques.


The Project
     The project is going to have a final investment of $39.000.000.
     BID(1) is going to support/finance $23.000.000 while LIF-UNL Consortium(2) is going to finance $16.000.000.
     LUC (2) is going to build a new development, quality control and production areas at LIF.


Tuberculosis today in Argentina

      Every year between 800 and 1000 people die from tuberculosis in Argentina.
     It is the second cause of death by infectious diseases and it has a high impact in vulnerable groups of the population.
     Many death are because people don’t respect the treatment. Many patients start the treatment but then they don’t finish it (10 - 20% in Argentina).


(*) UNL: Universidad Nacional del Litoral
(1) BID: IDB, Interamerican Development Bank.
(2) LIF- UNL Consortium (LUC) is an associative consortium between two public institutions through which the public production of medicines (LIF) take the knowledge from the national technological scientific system (UNL).

Monday, June 16, 2014

LIF's Board of Directors received Senator Miguel Lifschitz



     On June, 12th, Engineer. Miguel Lifschitz* (Rosario’s Provincial Senator) visited LIF.
     LIF’s Board of Directors welcomed the provincial legislator and then they had a meeting in which they gave information about the different activities and projects that LIF has been developing for Santa Fe province and for National Government.
     Mariano Cuvertino (Social Economy Director of Santa Fe Municipality) was another visitor that participated in the meeting together with Miguel Lifschitz.
     Carlos Arques, Guillermo Cleti, Diego Bruno and César Daniel Salomón (LIF’s Board of Directors), Carlos Minatti (Trustee) and Roberto Ganín (General Manager) participated by LIF.
     After the meeting, all of them visited the different areas.

*Engineer Miguel Lifschitz: former Mayor of Rosario city. Nowadays he is Provincial Senator by Rosario Department.

Sunday, June 8, 2014

Lecture about Public Health for General Practitioners.


El LIF participó del Curso de Salud Pública organizado por Residencias Médicas del Ministerio de Salud de la Provincia de Santa Fe.
The lecture took place on May, 23rd in Nodo Reconquista headquarters.
Daniel Salomón (LIF’s Director) gave a lecture about the management model of public production of medicines that LIF has made in Santa Fe Province for more than sixty years.
The main objectives of these activities are to give information to GPs* about the correct use of medicines, their public production, costs and safety update reports.
Other important people who attended this meeting were Elvia Gómez (Director of Biochemistry and Pharmacy - Santa Fe’s Health Ministry) and Laura Bugna (Safety Update Reports Coordinator - Santa Fe’s Health Ministry).

*GPs: General Practitioners.